staging ovarian classification cancers Flashcards
ovarian cancer
90 % of ovarian tumors are malignant epithelial tumors
- based to histology, immunohistochemistry and genetics what are the 5 subtypes
high grade serous 70% endometriod carcinoma 10% clear cell carcinoma 10% mucinous carcinoma 3% low grade serous <5%
What are the 3 subtypes of ovarian malignancy and their subtypes
epithelial 90+% 5 subtypes -high grade serous -low grade serous - endometriod -clear cell - mucinous
Germ cell tumor 3%
- dysgerminomas
- yolk sac tumors
- immature teratomas
Sex cord tumor 1-2%
mainly granolosa cell tumors
High grade serous tumors
how do they present
What is the genetic mutation?
The most common ovarian cancer
80% of patients present with advanced stage disease
<10 % at presentation have tumors confined to the ovary
Not associated with borderline tumors
TP53 mutation and BRCA abnormalities resulting in chromosome instability
Low grade serous tumors
how do they present
What is the genetic mutation?
Less common ovarian cancer
Usually contain a serous borderline component
KRAS and BRAF mutation
Ovarian / peritoneal / tubal cancers have the same staging
What is stage 1?
Stage 1: tumor confined to the ovaries or the fallopian tubes
What is Ovarian cancer stage T1a-No-Mo
IA: Tumor limited to 1 ovary (capsule intact) or fallopian tube; no tumor
on ovarian or fallopian tube surface; no malignant cells in the ascites or
peritoneal washings
B: Tumor limited to both ovaries (capsules intact) or fallopian tubes; no
tumor on ovarian or fallopian tube surface; no malignant cells in the
ascites or peritoneal washings
(1-5% of stage 1 cancers - second primary or metastatic?
- 1/3 obviously metastatic)
What is Ovarian cancer stage T1c-No-Mo
IC: Tumor limited to 1 or both ovaries or fallopian tubes, with any of the
following:
IC1: Surgical spill
IC2: Capsule ruptured before surgery or tumor on ovarian or fallopian tube surface
IC3: Malignant cells in the ascites or peritoneal washings
What constitutes ovarian surface involvement?
Surface involvement of the ovary or fallopian tube should be considered present only when tumor cells are exposed to the peritoneal cavity. It is characterized by exophytic papillary tumor on the surface of the ovary or fallopian tube or on the outer surface of a cystic neoplasm
replacing these organs; rarely, a smooth ovarian tumor surface will be shown to have an exposed layer of neoplastic epithelium. Assessment
of surface involvement requires careful gross examination.
Dense adhesions often cause rupture during surgery. Should these cases be
considered stage II?
Limited evidence suggests that dense adhesions of an apparent stage I tumor requiring sharp dissection (or when dissection results in tumor rupture) result in outcomes equivalent to tumors in stage II At
present, however, it is not clear whether upstaging based on dense
adhesions is warranted. A recent study suggests that it is not
Does rupture during surgery worsen prognosis in the absence of excrescences,
ascites, or positive washings?
This is controversial. Whereas some studies found that intraoperative capsule rupture portends a higher risk of disease recurrence, others did not In a multivariable analysis, capsule rupture and positive cytologic washings remained independent predictors
of worse disease-free survival. Rupture should be avoided during primary surgery of malignant ovarian tumors confined to the ovaries.
Data from several studies suggest that stage I Clear cell is more frequently stage IC compared with other cell types, possibly because of an increased risk of rupture
For ovarian cancer what is stage 2 disease
- this is less then 10% of ovarian cancers
Stage II: Tumor involves 1 or both ovaries or fallopian tubes with pelvic extension (below pelvic brim) or primary peritoneal cancer
What is stage 2a
IIA: Extension and/or implants on uterus and/or fallopian tubes and/ or ovaries
What is stage 2b
IIB: Extension to other pelvic intraperitoneal tissues
If tumor is in the sigmoid colon what stage is it?
Of note, the sigmoid colon is within the pelvis,
and therefore sigmoid involvement only is considered stage II
How is stage 2 disease treated
All treated with adjuvant chemo therefore subclassification decided not essential
What is stage 3 disease
Stage III: Tumor involves 1 or both ovaries or fallopian tubes, or primary peritoneal cancer, with cytologically or histologically confirmed spread to the peritoneum outside the pelvis and/or
metastasis to the retroperitoneal lymph nodes
Stage 3 a
What is stage 3Ai
stage 3Aii
Stage 3A2
T3a- N0/1 - M0
IIIA1: Positive retroperitoneal lymph nodes only cytologically or histologically proven):
IIIA1(i) Metastasis up to 10 mm in greatest dimension
IIIA1(ii) Metastasis more than 10 mm in greatest dimension
IIIA2: Microscopic extrapelvic (above the pelvic brim) peritoneal involvement with or without positive retroperitoneal lymph nodes
What is Stage 3 b
IIIB: Macroscopic peritoneal metastasis beyond the pelvis up to 2 cm in greatest dimension, with or without metastasis to the retroperitoneal lymph nodes
What is stage 3 C
IIIC: Macroscopic peritoneal metastasis beyond the pelvis more than 2 cm in greatest dimension, with or without metastasis to the retroperitoneal lymph nodes (includes extension of tumor to capsule of
liver and spleen without parenchymal involvement of either organ
What % of ovarian cancers present at stage 3?
IF the nodes are dissection what % of stage 1 pts will have nodal involvement
84% stage 3 c Stage 1 9% nodal involvement II 36% III 55% IV 88%
What is stage 4 disease?
Stage IV: Distant metastasis excluding peritoneal metastases
d includes patients with
parenchymal liver/splenic metastases and extra-abdominal metastases;
12%–21% of patients present with stage IV disease
What is stage 4 A and B
Stage IVA: Pleural effusion with positive cytology
Stage IVB: Parenchymal metastases and metastases to extra-abdominal
organs (including inguinal lymph nodes and lymph nodes outside of the
abdominal cavity)
Epithelial ovarian cancer prognostic factors
Age Stage Grade Ploidy Chemotherapy residual disease molecular markers
risk factors for ovarian epithelial cancer
early menarche late menopause nullip or low parity ? ovulation induction Infertility BRCA lynch FHx (outside of known genetic abnormality)